The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 24, 2025 | Thorp Clay | Director | Buy(P) | 15K | $0.92 | $14K |
| Jan 8, 2025 | Lasezkay George M | CEO, Director | Grant(A) | 500K | — | $0 |
| Jan 8, 2025 | Chong Ngai Hang Victor | Chief Medical Officer | Grant(A) | 250K | — | $0 |
| Jan 8, 2025 | Deignan Charles A. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Nov 1, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy(P) | 37K | $1.00 | $37K |
| Jun 24, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy(P) | 24K | $1.06 | $25K |
| Jun 20, 2024 | Shaffer Christy L | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Thorp Clay | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Humphries William D. | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Edwards Jeffrey L | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Croarkin Richard | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Hutson Nancy J | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Yerxa Benjamin R | Director | Grant(A) | 45K | — | $0 |
| Jun 20, 2024 | Gibney Anthony S | Director | Grant(A) | 45K | — | $0 |
| May 15, 2024 | Yerxa Benjamin R | Director | Buy(P) | 8K | $1.31 | $10K |
| Apr 18, 2024 | Gibney Anthony S | Director | Buy(P) | 93K | $1.30 | $121K |
| Apr 17, 2024 | Gibney Anthony S | Director | Buy(P) | 7K | $1.25 | $8K |
| Apr 15, 2024 | Gibney Anthony S | Director | Grant(A) | 45K | — | $0 |
| Mar 20, 2024 | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | Buy(P) | 30K | $1.60 | $48K |
| Mar 18, 2024 | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | Grant(A) | 450K | — | $0 |
| Feb 7, 2024 | Whitmore Bradford T | 10% Owner | Buy(P) | 444K | $1.35 | $600K |
| Feb 7, 2024 | Whitmore Bradford T | 10% Owner | Buy(P) | 444K | — | $0 |
| Jan 19, 2024 | Deignan Charles A. | Chief Financial Officer | Sell(S) | 13K | $1.28 | $17K |
| Jan 19, 2024 | Lasezkay George M | CEO, Director | Sell(S) | 18K | $1.27 | $23K |
| Jan 18, 2024 | Deignan Charles A. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Jan 18, 2024 | Lasezkay George M | CEO, Director | Grant(A) | 440K | — | $0 |
| Nov 1, 2023 | Whitmore Bradford T | 10% Owner | Buy(P) | 64K | $0.74 | $48K |
| Oct 31, 2023 | Whitmore Bradford T | 10% Owner | Buy(P) | 71K | $0.73 | $52K |
| Oct 30, 2023 | Whitmore Bradford T | 10% Owner | Buy(P) | 600 | $0.69 | $414 |
| Oct 3, 2023 | Hutson Nancy J | Director | Buy(P) | 10K | $0.86 | $9K |
| Sep 25, 2023 | Thorp Clay | Director | Buy(P) | 10K | $0.86 | $9K |
| Sep 22, 2023 | Humphries William D. | Director | Option exercise(M) | 23K | $0.40 | $9K |
| Sep 22, 2023 | Humphries William D. | Director | Option exercise(M) | 23K | — | $0 |
| Sep 18, 2023 | Lasezkay George M | CEO, Director | Grant(A) | 200K | — | $0 |
| Sep 18, 2023 | Deignan Charles A. | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Sep 13, 2023 | Deignan Charles A. | Chief Financial Officer | Option exercise(M) | 34K | $0.40 | $14K |
| Sep 13, 2023 | Deignan Charles A. | Chief Financial Officer | Option exercise(M) | 34K | — | $0 |
| Jun 22, 2023 | Yerxa Benjamin R | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2023 | Shaffer Christy L | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2023 | Hutson Nancy J | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2023 | Humphries William D. | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2023 | Edwards Jeffrey L | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2023 | Croarkin Richard | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2023 | Thorp Clay | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2023 | Ciulla Thomas | Chief Medical Officer | Sell(S) | 14K | $1.47 | $20K |
| Jan 19, 2023 | Deignan Charles A. | Chief Financial Officer | Sell(S) | 14K | $1.50 | $21K |
| Jan 19, 2023 | Lasezkay George M | CEO, Director | Sell(S) | 20K | $1.46 | $29K |
| Jan 10, 2023 | Ciulla Thomas | Chief Medical Officer | Sell(S) | 2K | $1.62 | $4K |
| Jan 4, 2023 | Ciulla Thomas | Chief Medical Officer | Grant(A) | 188K | — | $0 |
| Jan 4, 2023 | Deignan Charles A. | Chief Financial Officer | Grant(A) | 188K | — | $0 |
| Jan 4, 2023 | Lasezkay George M | CEO, Director | Grant(A) | 488K | — | $0 |
| Dec 31, 2022 | Ciulla Thomas | Chief Medical Officer | Grant(A) | 5K | $0.95 | $5K |
| Dec 21, 2022 | Thorp Clay | Director | Buy(P) | 14K | $1.02 | $14K |
| Dec 20, 2022 | Deignan Charles A. | Chief Financial Officer | Option exercise(M) | 24K | — | $0 |
| Dec 20, 2022 | Deignan Charles A. | Chief Financial Officer | Option exercise(M) | 24K | $0.40 | $9K |
| Dec 15, 2022 | Thorp Clay | Director | Other(J) | 9K | — | $0 |
| Dec 15, 2022 | Thorp Clay | Director | Other(J) | 1.4M | — | $0 |
| Nov 17, 2022 | Hutson Nancy J | Director | Buy(P) | 30K | $1.33 | $40K |
| Jun 30, 2022 | Ciulla Thomas | Chief Medical Officer | Grant(A) | 5K | $1.25 | $6K |
| Jun 22, 2022 | Shaffer Christy L | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2022 | Yerxa Benjamin R | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2022 | Hutson Nancy J | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2022 | Croarkin Richard | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2022 | Edwards Jeffrey L | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2022 | Humphries William D. | Director | Grant(A) | 30K | — | $0 |
| Jun 22, 2022 | Thorp Clay | Director | Grant(A) | 30K | — | $0 |
| Mar 2, 2022 | Yerxa Benjamin R | Director | Grant(A) | 30K | — | $0 |
| Jan 19, 2022 | Lasezkay George M | CEO, Director | Sell(S) | 11K | $2.12 | $23K |
| Jan 18, 2022 | Ciulla Thomas | Chief Medical Officer | Grant(A) | 139K | — | $0 |
| Jan 18, 2022 | Ciulla Thomas | Chief Medical Officer | Grant(A) | 46K | — | $0 |
| Jan 18, 2022 | Deignan Charles A. | Chief Financial Officer | Grant(A) | 139K | — | $0 |
| Jan 18, 2022 | Deignan Charles A. | Chief Financial Officer | Grant(A) | 46K | — | $0 |
| Jan 18, 2022 | Lasezkay George M | CEO, Director | Grant(A) | 293K | — | $0 |
| Jan 18, 2022 | Lasezkay George M | CEO, Director | Grant(A) | 98K | — | $0 |
| Jan 11, 2022 | Lasezkay George M | CEO, Director | Sell(S) | 5K | $2.46 | $13K |
| Jan 10, 2022 | Humphries William D. | Director | Option exercise(M) | 23K | — | $0 |
| Jan 10, 2022 | Humphries William D. | Director | Option exercise(M) | 23K | $0.15 | $3K |
| Oct 29, 2021 | Hutson Nancy J | Director | Option exercise(M) | 15K | — | $0 |
| Oct 29, 2021 | Hutson Nancy J | Director | Option exercise(M) | 25K | — | $0 |
| Oct 29, 2021 | Hutson Nancy J | Director | Option exercise(M) | 25K | $2.00 | $50K |
| Oct 29, 2021 | Hutson Nancy J | Director | Option exercise(M) | 15K | $2.09 | $31K |
| Sep 21, 2021 | Ciulla Thomas | Chief Medical Officer | Sell(S) | 3K | $6.40 | $16K |
| Sep 21, 2021 | Lasezkay George M | CEO, Director | Sell(S) | 4K | $6.46 | $23K |
| Sep 21, 2021 | Deignan Charles A. | Chief Financial Officer | Sell(S) | 3K | $6.41 | $18K |
| Sep 1, 2021 | Whitmore Bradford T | 10% Owner | Sell(S) | 213K | $6.89 | $1.5M |
| Aug 31, 2021 | Whitmore Bradford T | 10% Owner | Sell(S) | 108K | $6.96 | $749K |
| Aug 30, 2021 | Whitmore Bradford T | 10% Owner | Sell(S) | 99K | $7.06 | $702K |
| Aug 16, 2021 | Hutson Nancy J | Director | Buy(P) | 3K | $5.68 | $17K |
| Jun 21, 2021 | Lasezkay George M | CEO, Director | Sell(S) | 4K | $4.38 | $16K |
| Jun 21, 2021 | Deignan Charles A. | Chief Financial Officer | Sell(S) | 3K | $4.37 | $13K |
| Jun 10, 2021 | Hutson Nancy J | Director | Grant(A) | 25K | — | $0 |
| Jun 10, 2021 | Croarkin Richard | Director | Grant(A) | 25K | — | $0 |
| Jun 10, 2021 | Edwards Jeffrey L | Director | Grant(A) | 25K | — | $0 |
| Jun 10, 2021 | Humphries William D. | Director | Grant(A) | 25K | — | $0 |
| Jun 10, 2021 | Thorp Clay | Director | Grant(A) | 25K | — | $0 |
| Jun 10, 2021 | Shaffer Christy L | Director | Grant(A) | 25K | — | $0 |
| Feb 10, 2021 | Thorp Clay | Director | Sell(S) | 33K | $4.43 | $146K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).